alpha-galactosidase A (LSBC)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Namealpha-galactosidase A (LSBC)
Drug Alias NameFabry disease therapy (LSBC)alpha-galactosidase A (Large Scale Biology)Fabry disease therapy (Large Scale Biology)
ClassificationBiologics > Protein drugs > Enzyme
Mechanisms of Actionα-Galactosidase modulators
Targetsα-Galactosidase
Therapy Area/IndicationsFabry Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLarge Scale Biology Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLarge Scale Biology Corp
Active IndicationsN/A
Inactive IndicationsFabry Disease

Other Information

ATC CodeN/A
Related LinksN/A